Skandinaviska Enskilda Banken (SEB)’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
HA
CII
Skandinaviska Enskilda Banken (SEB)'s ONC Position: Q3 2023 in Review
Skandinaviska Enskilda Banken (SEB) sold out of BeOne Medicines Ltd (ONC) in Q3 2023, closing a stake of 2,711 shares — an estimated $483K sold.
Skandinaviska Enskilda Banken (SEB) first reported a position in ONC in Q2 2019 and held it in 17 quarters. The position peaked at $5.26M in Q2 2021. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.
- Skandinaviska Enskilda Banken (SEB) reported no remaining BeOne Medicines Ltd position as of Q3 2023 after selling out during the quarter.
- Skandinaviska Enskilda Banken (SEB) sold 2,711 BeOne Medicines Ltd shares in Q3 2023, an estimated $483K.
- Skandinaviska Enskilda Banken (SEB) first reported a position in BeOne Medicines Ltd in Q2 2019 and held it in 17 quarters.
- Skandinaviska Enskilda Banken (SEB)'s BeOne Medicines Ltd position peaked at $5.26M in Q2 2021.
- 201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.
Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2023, filed 9 Nov 2023.